These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 9528340
1. [Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma]. Tamura A, Oita T, Sakizono K, Nakajima T, Kasakura S. Rinsho Byori; 1998 Feb; 46(2):158-62. PubMed ID: 9528340 [Abstract] [Full Text] [Related]
2. [Tumor markers of hepatocellular carcinoma]. Kubo S, Matsukawa M. Gan To Kagaku Ryoho; 2004 Dec; 31(13):2203-6. PubMed ID: 15628773 [Abstract] [Full Text] [Related]
5. [Early detection of hepatocellular carcinoma with lectin reactive alpha-fetoprotein]. Matsuyama H, Morishita Y, Nakane K, Fukatsu T, Nakashima N. Rinsho Byori; 1994 Oct; 42(10):1021-8. PubMed ID: 7527871 [Abstract] [Full Text] [Related]
6. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T. Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [Abstract] [Full Text] [Related]
7. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kitabatake S, Kuzuya T, Nonogaki K, Shimizu J, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J, Satomura S. Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436 [Abstract] [Full Text] [Related]
8. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Shiraki K, Takase K, Tameda Y, Hamada M, Kosaka Y, Nakano T. Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756 [Abstract] [Full Text] [Related]
9. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [Abstract] [Full Text] [Related]
10. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R, Wang B, Ding H, Shen H, Li Y, Chen X. Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656 [Abstract] [Full Text] [Related]
11. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma. Tanaka Y, Kashiwagi T, Tsutsumi H, Nagasawa M, Toyama T, Ozaki S, Naito M, Ishibashi K, Azuma M. Hepatogastroenterology; 1999 Jan; 46(28):2464-8. PubMed ID: 10522021 [Abstract] [Full Text] [Related]
12. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Hayashi K, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Sone Y, Miyata A, Shimizu H, Satomura S. Am J Gastroenterol; 1999 Oct; 94(10):3028-33. PubMed ID: 10520864 [Abstract] [Full Text] [Related]
13. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ, Zhao XY, Li JH, Zhao GQ, Wang SX, Kong SL. Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1986-8. PubMed ID: 19062741 [Abstract] [Full Text] [Related]
14. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, Yoshida H, Akamatsu M, Kawabe T, Omata M. Hepatology; 2006 Dec 22; 44(6):1518-27. PubMed ID: 17133456 [Abstract] [Full Text] [Related]
15. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve]. Kim MJ, Bae KW, Seo PJ, Jeong IK, Kim JH, Lee BH, Bang KT, Kim DW, Song IH. Korean J Hepatol; 2006 Sep 22; 12(3):404-11. PubMed ID: 16998292 [Abstract] [Full Text] [Related]
16. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma]. Fujiyama S, Morishita T, Shibata J, Sato T. Gan To Kagaku Ryoho; 1989 Apr 22; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453 [Abstract] [Full Text] [Related]
17. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL. Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Kanke F, Satomura S. Cancer Sci; 2011 May 22; 102(5):1025-31. PubMed ID: 21244578 [Abstract] [Full Text] [Related]
18. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, Saishoji A, Kure T, Ohno K, Toyokura E, Imanaka D, Moriuchi A, Uto H, Oketani M, Hashiguchi T, Tsubouchi H. Oncol Rep; 2011 Nov 22; 26(5):1227-33. PubMed ID: 21874252 [Abstract] [Full Text] [Related]
19. [Tumor markers for hepatocellular carcinoma]. Tateishi R, Enooku K, Shiina S, Koike K. Nihon Rinsho; 2012 May 22; 70(5):821-7. PubMed ID: 22620007 [Abstract] [Full Text] [Related]
20. [The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma]. Li YL, Ma HB, Guo JX, Shi JB, Xu J, Liu AX, Yang LH, Li BA, Mao YL. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct 22; 22(5):336-8. PubMed ID: 19469167 [Abstract] [Full Text] [Related] Page: [Next] [New Search]